Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute

Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute

 

Award supports development of a pre-clinical cell-based assay platform to help scientists discover and test drug candidates for metastatic breast cancer